- Conflicts of Interest, Authorship, and Disclosures in Industry-Related Scientific Publications — Mayo Clinic Proceedings – We read with great interest the recent article by Hirsch1 and the accompanying editorial and appreciate that a venue for rational discourse has been opened. Recently, we have all witnessed increasing scrutiny and regulation of the relationship we, as clinical educators and investigators, have with our partners in industry and the continuing medical education (CME) providers with whom we work. What has been missing from this important dialogue is a concerted response from those who have worked with the pharmaceutical industry and providers of CME to present the opinion that these interactions are in fact of real value.
- Digital Pharma: Amgen’s online village | InPharm – Amgen has launched an online community for European healthcare professionals, patients and carers affected by autoimmune disease immune thrombycytopenia.
Related posts:
- Pharma Social Media Wiki; Sermo and AMA War of Words
- Online Support Groups, Diabetes and Twitter, and “Facebook for Pharmacists”
- All Things Health 2.0 November 23rd through December 4th
- Pharma and Social Media; Gaming against Cancer; Evidence for Online Education
- EthosCE: Mobile Text Messaging App for Tracking Live Meeting Attendance to be Presented at the Alliance for CME
Tags: CME, health 2.0, social media, thrombycytopenia
